Dr. O'Brien is the Director of the Vascular Biology Laboratory that focuses on Heat Shock Protein 27 (HSP27), a novel anti-atherosclerotic, anti-inflammatory and cholesterol lowering protein. He was the Chief of Cardiology at the University of Calgary from 2011-16. As well, he was the Director of Research at the Libin Cardiovascular Institute of Alberta (Calgary) from 2011-15.
Dr. O'Brien established his career in 1994 at the University of Ottawa Heart Institute, with a clinical practice that focused on coronary intervention and a research program focusing on better understanding the mechanisms involved in the development of atherosclerosis ("hardening of the arteries").
The O'Brien lab...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
